PHAT
PHATHOM PHARMA (PHAT)
NASDAQ
$7.02+$0.010 (+0.14%)
Price as of Oct 22, 2026 7:30 PM EDT
  • $568.7M
    Market Cap
  • -47.77%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 51
Valuation
PHAT
vs History
vs S&P 500
Profitability
-0
Growth
1
Low Earnings Volatility
2

Momentum Score

Score: 18
Valuation
PHAT
vs History
vs S&P 500
3-Month Momentum
-31.02%
12-Month Momentum
-44.57%
3-Month Risk Adjusted Momentum
-96.31%
12-Month Risk Adjusted Momentum
-72.58%

True Yield

N/A
Valuation
PHAT
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
0.03%
Net Debt Paydown Yield
-0.10%

Financial Health Score

Score: 85
Valuation
PHAT
vs History
vs S&P 500
Ohlson's O-Score
5